Carrier-Free Curcumin Nanoparticle for EGFR Positive Cancer Therapy


Reference #: 01472

The University of South Carolina is offering licensing opportunities for Carrier-free curcumin nanoparticle for EGFR positive cancer therapy


Due to their small size and large surface area, drug nanoparticles show great promise in improving drug delivery in patients.

Invention Description:

Most nanoparticle based drug delivery systems are composed of a carrier and a payload. However, due to the low drug loading content, premature drug release, non-standardized or uniform carrier structure, and difficulty in predicating the fate of the carrier, only a few nanomedicines have been approved by FDA.

Potential Applications:

Cancer treatment

Advantages and Benefits:

lower toxicity, high potency, better survival rate

Patent Information:
For Information, Contact:
Technology Commercialization
University of South Carolina
Peisheng Xu
© 2022. All Rights Reserved. Powered by Inteum